William Pickering
Stock Analyst at Argus Research
(1.77)
# 3,338
Out of 5,182 analysts
36
Total ratings
50%
Success rate
-2.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALLO Allogene Therapeutics | Maintains: Market Perform | $1.6 → $3.85 | $2.25 | +71.11% | 3 | Apr 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $925 → $921 | $744.44 | +23.72% | 4 | Apr 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $90 → $94 | $53.81 | +74.70% | 6 | Feb 25, 2026 | |
| BEAM Beam Therapeutics | Maintains: Outperform | $37 → $41 | $29.17 | +40.58% | 2 | Jan 21, 2026 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Outperform | n/a | $426.01 | - | 6 | Jan 12, 2026 | |
| BBIO BridgeBio Pharma | Initiates: Outperform | $94 | $74.52 | +26.14% | 1 | Dec 11, 2025 | |
| BHVN Biohaven | Downgrades: Market Perform | $34 → $9 | $9.59 | -6.15% | 3 | Nov 6, 2025 | |
| BIIB Biogen | Maintains: Market Perform | $155 → $157 | $180.67 | -13.10% | 1 | Nov 3, 2025 | |
| NTLA Intellia Therapeutics | Downgrades: Market Perform | $14 → $15 | $13.04 | +11.20% | 2 | Oct 28, 2025 | |
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $20.98 | -38.04% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $314 → $310 | $308.51 | +0.48% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $27 → $24 | $73.60 | -67.39% | 2 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $72.23 | - | 2 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $50.99 | -13.71% | 1 | Mar 21, 2023 |
Allogene Therapeutics
Apr 14, 2026
Maintains: Market Perform
Price Target: $1.6 → $3.85
Current: $2.25
Upside: +71.11%
Regeneron Pharmaceuticals
Apr 8, 2026
Maintains: Outperform
Price Target: $925 → $921
Current: $744.44
Upside: +23.72%
BioMarin Pharmaceutical
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $94
Current: $53.81
Upside: +74.70%
Beam Therapeutics
Jan 21, 2026
Maintains: Outperform
Price Target: $37 → $41
Current: $29.17
Upside: +40.58%
Vertex Pharmaceuticals
Jan 12, 2026
Upgrades: Outperform
Price Target: n/a
Current: $426.01
Upside: -
BridgeBio Pharma
Dec 11, 2025
Initiates: Outperform
Price Target: $94
Current: $74.52
Upside: +26.14%
Biohaven
Nov 6, 2025
Downgrades: Market Perform
Price Target: $34 → $9
Current: $9.59
Upside: -6.15%
Biogen
Nov 3, 2025
Maintains: Market Perform
Price Target: $155 → $157
Current: $180.67
Upside: -13.10%
Intellia Therapeutics
Oct 28, 2025
Downgrades: Market Perform
Price Target: $14 → $15
Current: $13.04
Upside: +11.20%
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $20.98
Upside: -38.04%
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $308.51
Upside: +0.48%
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $73.60
Upside: -67.39%
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $72.23
Upside: -
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $50.99
Upside: -13.71%